Skip to Content
OnKure discovers and developes next generation Histone Deacetylase (HDAC) inhibitors for the treatment of various cancers and neuropathies.
±õ²Ô»å³Ü²õ³Ù°ù²â:ÌıTherapeutics ​Funding Stage: Series B Round or beyond